Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4+ lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity

Antiviral Research

Volumn 29, Issue 1, 1996, Pages 91-93

  Vella, S ^a   Galluzzo, C ^a   Giannini, G ^a   Pirillo, M F ^a   Duncan, I ^a   Jacobsen, H ^a   Andreoni, M ^a   Sarmati, L ^a   Ercoli, L ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

HIV; Saquinavir; Zidovudine

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CD4 ANTIGEN; PROTEINASE INHIBITOR; SAQUINAVIR; VIRUS RNA; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SENSITIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE;

EID: 0029927979     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(95)00926-4     Document Type: Conference Paper

References (0)